within Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC54_BrinzolamideCombinations;

model BrinzolamideCombinations
  extends Pharmacolibrary.Drugs.ATC.S.S01EC54;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01EC54</td></tr><td>route:</td><td>ocular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Brinzolamide is a carbonic anhydrase inhibitor used primarily for the reduction of intraocular pressure in patients with ocular hypertension or open-angle glaucoma. In fixed combinations (such as with timolol), it offers enhanced efficacy for lowering eye pressure. It is approved and widely used in ophthalmology today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult patients; no specific published population PK modeling data for brinzolamide combinations (S01EC54) were identified.</p><h4>References</h4><ol><li><p>Iester, M (2008). Brinzolamide. <i>Expert opinion on pharmacotherapy</i> 9(4) 653–662. DOI:<a href=\"https://doi.org/10.1517/14656566.9.4.653\">10.1517/14656566.9.4.653</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18312166/\">https://pubmed.ncbi.nlm.nih.gov/18312166</a></p></li><li><p>Suzuki, G, et al., &amp; Kawamura, A (2021). Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations. <i>Current eye research</i> 46(3) 380–386. DOI:<a href=\"https://doi.org/10.1080/02713683.2020.1800046\">10.1080/02713683.2020.1800046</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32706598/\">https://pubmed.ncbi.nlm.nih.gov/32706598</a></p></li><li><p>Cvetkovic, RS, &amp; Perry, CM (2003). Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension. <i>Drugs &amp; aging</i> 20(12) 919–947. DOI:<a href=\"https://doi.org/10.2165/00002512-200320120-00008\">10.2165/00002512-200320120-00008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14565787/\">https://pubmed.ncbi.nlm.nih.gov/14565787</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end BrinzolamideCombinations;
